CVS Health Corp. Shares CVS,
changed little in premarket trading on Tuesday after pharmacies and the health benefits company reported profit and revenue in the fourth quarter that exceeded expectations. Net income fell to $ 973 million, or 74 cents a share, from $ 1.75 billion, or $ 1.34 a share, a year ago. With the exception of non-recurring items, adjusted earnings per share fell from $ 1.73 to $ 1.30, but exceeded the FactSet consensus of $ 1.24. Total revenue increased 4.0% to $ 69.55 billion, above the FactSet consensus of $ 68.73 billion. Among CVS’s business segments, all exceeded expectations, with pharmacy services revenue down 1.9% to $ 36.36 billion amid continued price compression, with retail / long-term care revenue rising 6 percent. , 6% to $ 24.06 billion, and healthcare revenues rise 11.4% to $ 19.10 billion. For 2021, CVS expects adjusted EPS of $ 7.39 to $ 7.55, compared to the $ 7.54 FactSet consensus. The company said it has administered more than 3 million COVID-19 vaccines in more than 40,000 long-term care units. The stock has gained 1.0% in the last three months, while the S&P 500 SPX,
advanced by 8.5%.